# A Trial to Investigate Safety and Pharmacokinetics of GRT6019, Including Food Effect, in Healthy Male Participants

> **NCT07317063** · PHASE1 · COMPLETED · sponsor: **Grünenthal GmbH** · enrollment: 18 (actual)

## Conditions studied

- Duchenne Muscular Dystrophy (DMD)

## Interventions

- **DRUG:** GRT6019

## Key facts

- **NCT ID:** NCT07317063
- **Lead sponsor:** Grünenthal GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-11-21
- **Primary completion:** 2026-01-06
- **Final completion:** 2026-01-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07317063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07317063, "A Trial to Investigate Safety and Pharmacokinetics of GRT6019, Including Food Effect, in Healthy Male Participants". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07317063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*